| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
967 |
703 |
$73K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
1,194 |
813 |
$65K |
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
1,442 |
731 |
$51K |
| 99000 |
|
1,906 |
1,437 |
$44K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
686 |
523 |
$30K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
815 |
589 |
$30K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
282 |
257 |
$14K |
| 87428 |
|
102 |
51 |
$6K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
214 |
144 |
$2K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
70 |
68 |
$2K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
99 |
83 |
$2K |
| 87210 |
|
256 |
220 |
$1K |
| 81002 |
|
125 |
100 |
$317.20 |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
26 |
12 |
$99.66 |